COMMENTARY

• Can Japan Generic Industry Accelerate Self-Reform? MHLW Panel Debate Now in Homestretch
  April 19, 2024

• With Honebuto 2024 Looming, Now Is the Time to Revisit Social Security Spending
  April 2, 2024

• With So Many of Its Demands Met, How Will Industry Oppose Off-Year Price Revisions in FY2025?
  March 12, 2024

• Is Case of Leqembi a “Steppingstone” to New CEA Price Adjustment Rule? Pharma Industry on Guard
  January 30, 2024

• Goals of the “Innovation Box” Tax Break in FY2024 Reform
  January 23, 2024

• Introduction of Elective Care to Mark Watershed for Long-Listed Drug Makers
  January 17, 2024

• Change of Tide in Reform: Lopsided Cost Cuts to Balanced Pro-Innovation Policy
  December 27, 2023

• Key Figures in Next Drug Pricing Reform Now All in Place, In What Direction Will They Go for Pro-Innovation Drive?
  November 15, 2023

• Predicting Clinical, Financial Impact of Hemophilia Gene Therapy in Japan
  November 7, 2023

• Reform Proposal Signals Perception Gap between Industry, Govt on Purpose of Market Expansion Re-Pricing
  October 31, 2023

• With 2nd Strategy Penned, Can Japan Play Catch-Up with US & Europe in SaMD Push?
  October 3, 2023

• Hopes to Nix Budget Ceiling Dashed, How Will Industry Get Its Message Across to Govt?
  September 4, 2023

• Chuikyo Embracing Industry Opinions in Early Phase of Drug Pricing Debate
  August 29, 2023

• Can “G1” Withdrawal Scheme Be Improved Enough to Serve Its Purpose?
  August 23, 2023

• Study Group of LDP Heavyweights Eyes “Drug Discovery Agency”
  August 7, 2023

• Expert Panel Report Failed to Delve into Annual Price Cuts, Irking Pharma Officials
  June 30, 2023

• Honebuto Policy Is Tailwind for Pharma, but Situation Remains Unpredictable
  June 22, 2023

• Will Wegovy Lead the Way in Changing Picture of Obesity Treatment in Japan?
  May 23, 2023

• Will Bill to Amend Medical Infrastructure Law Accelerate Drug Discovery for Rare Diseases?
  April 28, 2023

• Some Pharma Makers Leery of Further Cut into Off-Patent Brands in Japan
  April 3, 2023

ページ